Lukas J, Petersen B O, Holm K, Bartek J, Helin K
Division of Cancer Biology, Danish Cancer Society, DK-2100 Copenhagen, Denmark.
Mol Cell Biol. 1996 Mar;16(3):1047-57. doi: 10.1128/MCB.16.3.1047.
The E2F family of transcription factors regulate genes, whose products are essential for progression through the mammalian cell cycle. The transcriptional activity of the E2Fs is inhibited through the specific binding of the retinoblastoma protein, pRB, and the pRB homologs p107 and p130 to their transactivation domains. Seven members of the E2F transcription factor family have been isolated so far, and we were interested in investigating the possible contribution of the various E2Fs to cell cycle control. By presenting the results of the generation of cell lines with tetracycline-controlled expression of E2F-1 and E2F-4 and microinjection of expression plasmids for all members of the E2F family, we demonstrate here that the pRB-associated ED2Fs (E2F-1, E2F-2, and E2F-3) all induce S phase in quiescent rate fibroblasts when expressed alone. In contrast, the p107/p130-associated E2Fs require the coexpression of the heterodimeric partner DP-1 to promote S-phase entry and accelerate G1 progression. Furthermore, the pRB-associated E2Fs were all able to overcome a G1 arrest mediated by the p16INK4 tumor suppressor protein, and E2F-1 was shown to override a G1 block mediated by a neutralizing antibody to cyclin D1. The p16INK4-induced G1 arrest was not affected by expression of E2F-4, E2F-5, or DP-1 alone, but simulataneous expression of E2F-4 and DP-1 could overcome this block. Our results demonstrate that the generation of E2F activity is rate limiting for G1 progession, is sufficient to induce S-phase entry, and overcomes a p16-mediated G1 block, and since E12F-1, E2F-2, and E2F-3 are associated with pRB, they are the most likely downstream effectors in the p126-cyclin D-pRB pathway. Furthermore, our date suggest that the two subsets of E2Fs are regulated by distinct mechanisms and/or that they have distinct functions in cell cycle control. Since E2F-4 and E2F-5 cannot promote S-phase entry by themselves, our results may provide an explanation for the apparent lack of aberrations in p107 or p130 in human cancer.
E2F转录因子家族调控着一些基因,这些基因的产物对于哺乳动物细胞周期的进程至关重要。E2F的转录活性通过视网膜母细胞瘤蛋白pRB以及pRB同源物p107和p130与它们的反式激活结构域的特异性结合而受到抑制。到目前为止,已分离出E2F转录因子家族的七个成员,我们感兴趣的是研究各种E2F对细胞周期调控可能产生的作用。通过展示用四环素控制E2F-1和E2F-4表达的细胞系的构建结果以及对E2F家族所有成员表达质粒的显微注射,我们在此证明,与pRB相关的E2F(E2F-1、E2F-2和E2F-3)单独表达时,均可在静止的成纤维细胞中诱导S期。相反,与p107/p130相关的E2F需要异二聚体伙伴DP-1的共表达来促进进入S期并加速G1期进程。此外,与pRB相关的E2F均能够克服由p16INK4肿瘤抑制蛋白介导的G1期阻滞,并且已证明E2F-1能够克服由细胞周期蛋白D1中和抗体介导的G1期阻滞。单独表达E2F-4、E2F-5或DP-1不会影响p16INK4诱导的G1期阻滞,但同时表达E2F-4和DP-1能够克服这种阻滞。我们的结果表明,E2F活性的产生是G1期进程的限速因素,足以诱导进入S期,并能克服p16介导的G1期阻滞,并且由于E2F-1、E2F-2和E2F-3与pRB相关,它们是p16-细胞周期蛋白D-pRB途径中最可能的下游效应物。此外,我们的数据表明,E2F的两个亚群受不同机制调控和/或它们在细胞周期调控中具有不同功能。由于E2F-4和E2F-5自身无法促进进入S期,我们的结果可能为人类癌症中p107或p130明显缺乏异常提供一种解释。